VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MDXH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MDXHMDxHealth S.A.
$0.57$29M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMDXHBalance Sheet

MDxHealth S.A. (MDXH) Balance Sheet

22Y historyFree accessUpdated daily

The company's financial position is increasingly vulnerable, with total debt rising to $95.1 million by 2025Q4 and equity deteriorating into a negative $12.1 million balance.

Income StatementBalance SheetCash FlowRatios

MDXH Balance Sheet

Annual statement

MDXH Balance Sheet

MDxHealth S.A. (MDXH) balance sheet — 22-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04
Total Current Assets43.03M53.41M66.89M38.16M29.15M66.61M23.09M30.91M47.86M39.32M51.49M44.65M28.11M27.62M18.91M18.04M17.7M32.63M47.88M53.18M45.76M14.43M7.48M
Cash & Short-Term Investments19.21M29.03M46.8M22.38M15.6M58.59M15.95M22.1M26.2M16.83M30.51M30.52M18.9M24.68M15.49M14.42M14.09M25.84M42.6M48.26M43.3M11.16M310.43K
Cash Only19.21M29.03M46.8M22.38M15.5M58.5M15.95M22.05M26.2M16.83M30.51M30.52M18.9M24.68M15.49M14.42M14.09M25.84M42.6M48.26M43.3M11.16M310.43K
Short-Term Investments0000101K89K051K000000000000000
Accounts Receivable14.93M14.73M14.53M11.27M9.36M4.58M3.89M6.64M19.13M19.93M18.54M11.21M7.99M2.36M2.69M3.32M3.07M4.59M3.87M0155.67K0706.27K
Days Sales Outstanding34.8849.8358.958.6192.1775.276.99205.81246.42179.59226.51234.17254.16113.98200347.48332.47459.4335.6-15.54-490.12
Inventory6.43M6.74M3.87M2.78M2.33M1.91M2.32M1.19M1.81M1.92M1.48M1.43M860K171K122.99K00000000
Days Inventory Outstanding30.4856.6540.4538.6247.6259.7481.4436.4756.668.6553.4375.4348.6410.7737.59--------
Other Current Assets2.46M940K135K146K151K504K52K54K104K24K-37K119K46K339K94K61K36.22K07562.88M1.32M1.26M5.26M
Total Non-Current Assets89.06M94.54M90.43M90.97M89.99M8.47M8.77M9.72M17.61M19.2M16.23M13.1M2.84M1.76M1.1M999.29K1.47M2.83M6.49M5M2.77M2.38M1.28M
Property, Plant & Equipment11.9M14.68M12.98M9.95M7.89M5.02M3.71M2.45M2.07M2.57M2.26M1.89M724K781K1.06M942.26K770.05K1.46M1.99M2.55M1.98M627.73K691.36K
Fixed Asset Turnover12.11x7.35x6.94x7.06x4.69x4.43x4.98x4.81x13.66x15.77x13.22x9.25x15.85x9.67x4.65x3.70x4.38x2.49x2.12x1.51x1.84x5.81x0.76x
Goodwill39.25M38.95M35.93M35.93M35.93M0001.15M1.15M1.15M1.15M00000000000
Intangible Assets36.71M39.42M40.59M44.34M46.17M3.45M5.06M7.27M14.39M15.49M12.83M10.03M2.01M981K37.03K57.03K62.51K70.2K2.29M106.43K227K320.97K521.91K
Long-Term Investments4.47M1.5M936K763K000000033K00000000000
Other Non-Current Assets0000010000033K105K000642.37K1.3M2.21M2.34M564.88K1.43M67.78K
Total Assets132.09M147.95M157.33M129.13M119.14M75.07M31.86M40.63M65.48M58.52M67.72M57.74M30.95M29.38M20M19.04M19.18M35.46M54.36M58.18M48.54M16.81M8.76M
Asset Turnover1.08x0.73x0.57x0.54x0.31x0.30x0.58x0.29x0.43x0.69x0.44x0.30x0.37x0.26x0.25x0.18x0.18x0.10x0.08x0.07x0.08x0.22x0.06x
Asset Growth %17.27%-5.96%21.84%8.39%58.69%135.66%-21.59%-37.95%11.88%-13.59%17.28%86.55%5.34%46.91%5.04%-0.7%-45.93%-34.77%-6.56%19.87%188.76%91.8%-
Total Current Liabilities37.4M49.53M42.66M19.52M18.28M16.43M13.02M10.43M11.48M13.12M12.59M10.82M7.09M4.85M3.95M4.01M4.08M7.73M7.18M6.47M5.47M3.09M1.56M
Accounts Payable10.57M10.33M8M8.81M10.18M7.46M5.32M4.96M6.45M8.05M7.55M6.61M4.13M2.31M1.43M753.78K1.05M3.84M3.51M3.89M3.71M00
Days Payables Outstanding52.4786.8183.66122.45208.3233.07186.42151.7202.14288.16272.62349.41233.38145.74436.4798.04775.385.47K3.79K2.16K18.68K--
Short-Term Debt01.9M324K643K616K4.44M2.82M565K147K191K430K440K001.43M0872.46K000000
Deferred Revenue (Current)000472K003.22M04.36M3.82M3.54M2.9M00-2.19M01.05M010000
Other Current Liabilities25.03M37.31M26.41M2.9M2.33M961K-2.31M909K402K883K1.08M975K1.14M958K-424.6K1.87M-546.61K2.22M945.23K2.58M1.75M1.92M491.97K
Current Ratio1.15x1.08x1.57x1.95x1.59x4.05x1.77x2.96x4.17x3.00x4.09x4.12x3.96x5.70x4.78x4.50x4.34x4.22x6.67x8.22x8.37x4.67x4.80x
Quick Ratio0.98x0.94x1.48x1.81x1.47x3.94x1.59x2.85x4.01x2.85x3.97x3.99x3.84x5.66x4.75x4.50x4.34x4.22x6.67x8.22x8.37x4.67x4.80x
Cash Conversion Cycle12.8919.6715.7-25.22-68.5-98.12-27.9990.58100.89-39.927.33-39.8169.42-20.98-198.81--------
Total Non-Current Liabilities125.09M110.51M99.83M102.4M91.54M11.74M12.99M10.48M1.88M1.86M2.39M2.65M83K3.27M22.48K362.9K832.56K798.04K1.74M1.96M863.15K1.77M161.32K
Long-Term Debt96.41M84.71M50.97M35.56M34.91M7.65M10.28M9.05M0147K108K408K000207.37K0000000
Capital Lease Obligations30.44M8.51M7.41M3.58M3.09M2.62M2.02M735K262K376K0000002.66K001.46K2.64K5.92K16.27K
Deferred Tax Liabilities00000000575K616K729K842K0002.26M1.88M000000
Other Non-Current Liabilities21.05M17.3M41.45M63.26M53.54M1.47M690K690K1.04M661K1.55M1.39M83K000642.37K581.7K1.74M1.96M860.51K1.77M145.05K
Total Liabilities162.49M160.05M142.49M121.92M109.82M28.17M26.01M20.9M13.36M14.97M14.98M13.48M7.18M4.85M3.98M4.37M4.92M8.53M8.92M8.43M6.33M4.86M1.72M
Total Debt105.85M95.11M60.06M41.27M39.79M15.56M15.87M11M526K884K538K848K001.43M207.37K5.32K01.39K4.37K6.6K15.4K29.82K
Net Debt86.64M66.08M13.27M18.89M24.29M-42.94M-82K-11.05M-25.68M-15.94M-29.97M-29.67M-18.9M-24.68M-14.06M-14.21M-14.08M-25.84M-42.6M-48.26M-43.29M-11.14M-280.61K
Debt / Equity-3.48x-4.05x5.72x4.27x0.33x2.71x0.56x0.01x0.02x0.01x0.02x--0.09x0.01x0.00x-0.00x0.00x0.00x0.00x0.00x
Debt / EBITDA-6.78x----------------------
Net Debt / EBITDA-5.55x----------------------
Interest Coverage-0.96x-1.91x-3.94x-6.47x-15.06x-14.47x-17.70x-83.64x-395.23x-101.65x--143.53x-663.30x-803.55x-32.29x-115.52x-91.74x-714.07x-1131.52x-9.00x-8.53x-24.71x-33.56x
Total Equity-30.4M-12.09M14.84M7.21M9.31M46.9M5.85M19.72M52.12M43.55M52.74M44.26M23.78M24.54M16.02M14.67M14.26M26.94M45.44M49.75M42.21M11.95M7.04M
Equity Growth %-3328.88%-181.49%105.9%-22.62%-80.14%701.83%-70.35%-62.15%19.68%-17.43%19.16%86.16%-3.1%53.12%9.22%2.88%-47.05%-40.73%-8.66%17.87%253.22%69.65%-
Book Value per Share-0.58-0.240.300.280.593.850.703.159.058.7211.4510.726.848.177.268.5310.8220.4438.3846.0449.2026.1518.77
Total Shareholders' Equity-30.4M-12.09M14.84M7.21M9.31M46.9M5.85M19.72M52.12M43.55M52.74M44.26M23.78M24.54M16.02M14.67M14.26M26.94M45.44M49.75M42.21M11.95M7.04M
Common Stock219.21M219.21M214.67M173.93M148.42M143.42M76.72M70.72M53.88M45.95M45.85M42.79M37.83M35.48M25.33M18.16M13.99M73.2M70.98M66.31M53.62M27.48M19.25M
Retained Earnings-423.43M-403.03M-369.51M-331.45M-288.35M-244.3M-215.3M-186.64M-143.54M-111.09M-98.8M-85.63M-71.15M-55.82M-38.02M-25.63M-17.06M-64.68M-14.19M-30.11M-14.09M-16.02M-12.53M
Treasury Stock00000000000000000000000
Accumulated OCI-654K18.55M-615K11.55M-3.94M-5.39M8.08M-704K-1.17M1.24M-686K-722K-433K-683K-76.7K00000000
Minority Interest00000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and solvency pressure

Eroding Equity and Rising Liabilities

As reported in recent financial statements, MDXH's equity position has deteriorated into a negative $12.1 million balance by 2025Q4, driven by the accumulation of $403 million in retained losses that significantly outpace the company's ability to generate organic capital through its diagnostic service operations.

The shift from positive equity in previous periods to a deficit indicates that the company is effectively operating on borrowed capital and external funding. This trajectory suggests that the business model has yet to achieve the scale necessary to offset its historical losses, leaving the balance sheet in a precarious state.

Leverage Burdening Future Cash Flows

Based on MDXH's reported figures, total debt has climbed to $95.1 million as of 2025Q4, representing a substantial increase from the $15.1 million observed in 2021Q2, which underscores a growing reliance on debt financing to sustain operations in the absence of consistent positive free cash flow.

The rising debt load relative to the company's limited asset base suggests that interest obligations may increasingly constrain the capital available for commercial expansion. Investors should monitor whether this leverage is being used to fund high-return growth initiatives or merely to bridge the gap created by persistent operating losses.

Tightening Runway Amidst Operational Burn

According to recent SEC filings, MDXH's current ratio has compressed to 1.08 in 2025Q4, down from a peak of 4.05 in 2021Q4, signaling a narrowing buffer against short-term liquidity shocks as cash reserves dwindle to $29 million against a backdrop of ongoing operational cash outflows.

A current ratio hovering near parity suggests that the company has minimal room for error in its working capital management. Any delay in reimbursement collections or unexpected spikes in operating costs could force the company to seek dilutive financing or further debt, potentially impacting shareholder value.

Goodwill Impairment and Asset Quality

As indicated by the latest balance sheet data, goodwill has risen to $38.9 million, representing over 26% of total assets, which warrants further investigation into the carrying value of acquired diagnostic assets relative to their actual contribution to current revenue streams and long-term profitability.

The concentration of intangible assets on the balance sheet creates a risk of future impairment charges if the acquired technologies fail to meet projected commercial adoption targets. This reliance on goodwill to support the asset base may mask the underlying weakness in the company's tangible asset productivity.

MDXH — Frequently Asked Questions

Quick answers to the most common questions about buying MDXH stock.

What are the total assets of MDxHealth S.A. (MDXH)?

As of 2025, MDxHealth S.A. (MDXH) had total assets of $148.0M including $53.4M in current assets.

How much debt does MDxHealth S.A. (MDXH) have?

MDxHealth S.A. (MDXH) carries total debt of $95.1M, offset by $29.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of MDxHealth S.A.?

MDxHealth S.A. (MDXH) has total shareholders' equity (book value) of $-12.1M ($-0.24 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is MDxHealth S.A.'s current ratio and liquidity?

MDxHealth S.A. (MDXH) reported a current ratio of 1.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.